Yong Shin - Amicogen CEO and Pres

092040 Stock  KRW 3,650  50.00  1.39%   

CEO

Shin Yong Cheol is Chief Executive Officer and Director of Amicogen, Inc. Shin also serves as a professor of Gyeongsang National University. Shin holds a Bachelor degree from Seoul National University, as well as a Master and a Doctorate degrees from Korea Advanced Institute of Science and Technology.
Age 52
Phone82 5 5759 6161
Webhttp://www.amicogen.com

Amicogen Management Efficiency

Amicogen's management efficiency ratios could be used to measure how well Amicogen manages its routine affairs as well as how well it operates its assets and liabilities.
Amicogen has accumulated 8.21 B in total debt with debt to equity ratio (D/E) of 18.9, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Amicogen has a current ratio of 1.58, which is within standard range for the sector. Debt can assist Amicogen until it has trouble settling it off, either with new capital or with free cash flow. So, Amicogen's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Amicogen sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Amicogen to invest in growth at high rates of return. When we think about Amicogen's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 1 records

CEO Age

Byeong ParkParadise Co
58
Amicogen, Inc. operates as an industrial biotechnology company in South Korea and internationally. The company was founded in 2000 and is headquartered in Jinju, South Korea. Amicogen is traded on Korean Securities Dealers Automated Quotations in South Korea. Amicogen (092040) is traded on KOSDAQ in Korea and employs 208 people.

Management Performance

Amicogen Leadership Team

Elected by the shareholders, the Amicogen's board of directors comprises two types of representatives: Amicogen inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Amicogen. The board's role is to monitor Amicogen's management team and ensure that shareholders' interests are well served. Amicogen's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Amicogen's outside directors are responsible for providing unbiased perspectives on the board's policies.
Young Kim, Managing Sales
Zhe Piao, Chief RD
SooDong Kim, Managing Sales
Yong Shin, CEO and Pres

Amicogen Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Amicogen a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Amicogen

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Amicogen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amicogen will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Amicogen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Amicogen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Amicogen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Amicogen to buy it.
The correlation of Amicogen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Amicogen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Amicogen moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Amicogen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in Amicogen Stock

Amicogen financial ratios help investors to determine whether Amicogen Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Amicogen with respect to the benefits of owning Amicogen security.